Recursion Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75629V1044
SecurityMX:RXRX / Recursion Pharmaceuticals, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership2,612,277 shares
Latest Disclosed Value $ 8,019,690
Millennium Management Llc ownership in RXRX / Recursion Pharmaceuticals, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 2,612,277 shares of Recursion Pharmaceuticals, Inc. (MX:RXRX) valued at $8,019,690 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,495,839 shares of Recursion Pharmaceuticals, Inc.. This represents a change in shares of 74.64% during the quarter.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (RXRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:RXRX / Recursion Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 2,612,277 1,116,438 74.64 8,020 31.09 0.0033
2026-02-17 2025-12-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 1,495,839 1,495,839 6,118 0.0026
2025-11-14 2025-09-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 0 -739,408 -100.00 0 -100.00
2025-08-14 2025-06-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 739,408 237,300 47.26 3,741 40.85 0.0018
2025-05-15 2025-03-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 502,108 473,798 1,673.61 2,656 1,290.58 0.0014
2025-02-14 2024-12-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 28,310 -10,473 -27.00 191 -25.10 0.0001
2024-11-14 2024-09-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 38,783 38,783 256 0.0001
2024-08-14 2024-06-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 0 -11,077 -100.00 0 -100.00
2024-05-15 2024-03-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 11,077 11,077 110 0.0000
2024-02-14 2023-12-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 0 -658,355 -100.00 0 -100.00
2023-11-14 2023-09-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 658,355 658,355 5,036 0.0025
2023-08-14 2023-06-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 0 -646,610 -100.00 0 -100.00
2023-05-15 2023-03-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 646,610 -48,763 -7.01 4,313 -19.55 0.0025
2023-02-14 2022-12-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 695,373 455,977 190.47 5,361 110.48 0.0030
2022-11-14 2022-09-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 239,396 -143,778 -37.52 2,547 -18.34 0.0015
2022-08-15 2022-06-30 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 383,174 -111,978 -22.61 3,119 -12.02 0.0019
2022-05-16 2022-03-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 495,152 461,323 1,363.69 3,545 512.26 0.0019
2022-02-14 2021-12-31 13F RECURSION PHARMACEUTICALS IN CL A 75629V104 33,829 33,829 579 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F RECURSION PHARMACEUTICALS IN CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F RECURSION PHARMACEUTICALS IN CL A Call 31,700 -68.30 209 -72.27 n/a n/a n/a
2024-08-14 2024-06-30 13F RECURSION PHARMACEUTICALS IN CL A Call 100,000 142.13 750 82.48 n/a n/a n/a
2024-05-15 2024-03-31 13F RECURSION PHARMACEUTICALS IN CL A Call 41,300 412 n/a n/a n/a
2022-05-16 2022-03-31 13F RECURSION PHARMACEUTICALS IN CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F RECURSION PHARMACEUTICALS IN CL A Call 60,000 1,028 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.